Generic Imatinib Update
On February 1, 2016, there was a commercial launch of the generic version of imatinib mesylate (Gleevec) which is approved for CML patients by the FDA. As the first to file for generic marketing [...]
On February 1, 2016, there was a commercial launch of the generic version of imatinib mesylate (Gleevec) which is approved for CML patients by the FDA. As the first to file for generic marketing [...]
Dr. Wong presents, "The Role of Integrative Medicine in Cancer Treatment" at Life Fest 2016.
Dr. Arun Singh presents, "Current Clinical Management of GIST" at Life Fest 2016.
The Gift of Time theme applies to everyone. If you are newly diagnosed, a long-term survivor, a caregiver, a doctor, a student and just about anyone – this is an opportunity to recognize how valuable time is.
The following are summaries of two of the Wild Type GIST parallel track sessions at Life Fest, 2016, submitted by Rebecca Bensenhaver of GSI International. "I was fortunate to be able to attend Life [...]
This is the 16 year commemoration video that highlights the incredible collaboration among patients, caregivers, the medical community, government, and industry to make the initiation of GIST treatment possible. [...]
The Life Raft Group is pleased to announce the release of the tenth issue of The GIST Cancer Journal, the official journal of the Life Raft Group. The journal is intended to serve as [...]
Life Raft Group Programs and Services
Finding and Participating in GIST Clinical Trials
GIST Pathology and Mutational Testing Update